BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, Scaradavou A, Kernan NA, O'Reilly RJ, Giralt S, Jakubowski A, Koehne G, Papadopoulos EB, Ponce DM, Sauter C, Papanicolaou G, Barker JN. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma. 2015;56:1799-1805. [PMID: 25224458 DOI: 10.3109/10428194.2014.963079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Johnsrud JJ, Nguyen IT, Domingo W, Narasimhan B, Efron B, Brown JW. Letermovir Prophylaxis Decreases Burden of Cytomegalovirus (CMV) in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant. Biol Blood Marrow Transplant 2020;26:1963-70. [PMID: 32653623 DOI: 10.1016/j.bbmt.2020.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hill JA, Zamora D, Xie H, Thur LA, Delaney C, Dahlberg A, Pergam SA, Leisenring WM, Boeckh M, Milano F. Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients. Blood Adv 2021;5:3113-9. [PMID: 34402885 DOI: 10.1182/bloodadvances.2021004362] [Reference Citation Analysis]
3 Whited LK, Handy VW, Hosing C, Chow E. Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation. Pharmacotherapy 2020;40:773-87. [PMID: 32497299 DOI: 10.1002/phar.2433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E. Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant 2017;23:882-96. [PMID: 28279825 DOI: 10.1016/j.bbmt.2017.03.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 14.0] [Reference Citation Analysis]
6 Sharma P, Gakhar N, MacDonald J, Abidi MZ, Benamu E, Bajrovic V, Purev E, Haverkos BM, Tobin J, Kaiser J, Chase S, Miller M, Weinberg A, Gutman JA. Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation. Bone Marrow Transplant 2020;55:780-6. [PMID: 31664185 DOI: 10.1038/s41409-019-0730-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
7 Jaing TH, Chang TY, Chen SH, Wen YC, Yu TJ, Lee CF, Yang CP, Tsay PK. Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation. Medicine (Baltimore) 2019;98:e14172. [PMID: 30681583 DOI: 10.1097/MD.0000000000014172] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mavropoulou E, Ternes K, Mechie NC, Bremer SCB, Kunsch S, Ellenrieder V, Neesse A, Amanzada A. Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome. BMJ Open Gastroenterol 2019;6:e000258. [PMID: 30899538 DOI: 10.1136/bmjgast-2018-000258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Hill JA, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, Delaney C, Milano F. A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients. Biol Blood Marrow Transplant 2018;24:2094-100. [PMID: 29753836 DOI: 10.1016/j.bbmt.2018.05.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
10 Babady NE, Cheng C, Cumberbatch E, Stiles J, Papanicolaou G, Tang YW. Monitoring of cytomegalovirus viral loads by two molecular assays in whole-blood and plasma samples from hematopoietic stem cell transplant recipients. J Clin Microbiol 2015;53:1252-7. [PMID: 25653404 DOI: 10.1128/JCM.03435-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
11 Fabrizio VA, Rodriguez-Sanchez MI, Mauguen A, Dahi PB, Doubrovina E, O'Reilly RJ, Prockop SE. Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses. Blood Adv 2021;5:496-503. [PMID: 33496746 DOI: 10.1182/bloodadvances.2020002735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ponce DM, Hilden P, Devlin SM, Maloy M, Lubin M, Castro-Malaspina H, Dahi P, Hsu K, Jakubowski AA, Kernan NA, Koehne G, O'Reilly RJ, Papadopoulos EB, Perales MA, Sauter C, Scaradavou A, Tamari R, van den Brink MR, Young JW, Giralt S, Barker JN. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant 2015;21:1985-93. [PMID: 26238810 DOI: 10.1016/j.bbmt.2015.07.029] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
13 Politikos I, Lavery JA, Hilden P, Cho C, Borrill T, Maloy MA, Giralt SA, van den Brink MRM, Perales MA, Barker JN. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood Adv 2020;4:191-202. [PMID: 31935291 DOI: 10.1182/bloodadvances.2019000836] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
14 Green ML. Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies. Clin Chest Med 2017;38:295-305. [PMID: 28477640 DOI: 10.1016/j.ccm.2016.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
15 Albano MS, Ciubotariu R, Dobrila L, Tarnawski M, DeLeon M, Watanabe C, Krishnan S, Scaradavou A, Rubinstein P. Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency. Transfusion. 2017;57:2768-2774. [PMID: 28758211 DOI: 10.1111/trf.14257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Reed DR, Petroni GR, West M, Jones C, Alfaraj A, Williams PG, DeGregory K, Grose K, Monson S, Varadarajan I, Volodin L, Donowitz GR, Kindwall-Keller TL, Ballen KK. Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther 2021:S1658-3876(21)00052-2. [PMID: 34161832 DOI: 10.1016/j.hemonc.2021.05.001] [Reference Citation Analysis]
17 Bonifazi F, Dan E, Labopin M, Sessa M, Guadagnuolo V, Ferioli M, Rizzi S, De Carolis S, Sinigaglia B, Motta MR, Bontadini A, Giudice V, Martinelli G, Arpinati M, Cavo M, Bonafé M, Storci G. Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study. Bone Marrow Transplant 2019;54:717-25. [PMID: 30232415 DOI: 10.1038/s41409-018-0335-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hanash AM. Does GVHD make amateurs out of professional APCs? Blood 2015;126:1404-5. [PMID: 26384284 DOI: 10.1182/blood-2015-07-657163] [Reference Citation Analysis]
19 Olson AL, Politikos I, Brunstein C, Milano F, Barker J, Hill JA; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Guidelines for Infection Prophylaxis, Monitoring and Therapy in Cord Blood Transplantation. Transplant Cell Ther 2021;27:359-62. [PMID: 33965172 DOI: 10.1016/j.jtct.2021.01.024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Montoro J, Piñana JL, Moscardó F, Sanz J. Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors. Mediterr J Hematol Infect Dis. 2016;8:e2016051. [PMID: 27872731 DOI: 10.4084/MJHID.2016.051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]